Monday, December 30, 2019

Human Rights in Age of Social Media, Big Data, and AI

By Molly Galvin | Sept. 23, 2019
In just a few years, digital technologies have allowed faster mobilization in response to humanitarian crises, better documentation of war crimes in conflict zones like Syria and Yemen, and more accessible platforms for organizing peaceful demonstrations around the world.   
However, while social media and big data can be powerful tools for anticipating, analyzing, and responding to human rights concerns, these technologies also pose unprecedented challenges. Social media has been weaponized to spread disinformation, interfere in elections, and promote and incite violence. And websites and apps are continuously collecting broad swaths of data on their users — often without them being aware of it, or of how or where their personal information is being used or stored. 
A recent symposium at the National Academies of Sciences, Engineering, and Medicine, organized by the Academies’ Committee on Human Rights, brought together leading experts on human rights and technology for an-depth exploration of these issues.
“Human rights — its vocabulary, its framework, its vision — provides a basis for restraining the worst intrusions and violations of the digital world, and promoting its best.” — David Kaye, UN Special Rapporteur and clinical professor of law at the University of California, Irvine
“Human rights — its vocabulary, its framework, its vision — provides a basis for restraining the worst intrusions and violations of the digital world, and promoting its best,” said keynote speaker David Kaye, United Nations Special Rapporteur on the promotion and protection of the right to freedom of opinion and expression and clinical professor of law at the University of California, Irvine.  “Not in some kind of vague … sense of what human rights might be, but in the specifics of human rights law.”
Although Americans tend to think of rights as guaranteed by the U.S. Constitution, international treaties bind countries around the world to uphold rights such as privacy, freedom of opinion and expression, and nondiscrimination, said Kaye.  “How do we get from holding states accountable to holding [digital technology companies] accountable? There is a huge amount of space to work with in this foundation of human rights thinking to make it relevant to the companies, to make it relevant to governments [who regulate companies].” 
Digital Power for Good
Throughout the symposium’s panel discussions, researchers and practitioners shared many positive examples of the power of digital technologies to advance humanitarian goals.  For instance, after the horrific 2012 gang rape and fatal assault of a young woman in Delhi, India, panelist ElsaMarie D’Silva left a 20-year career in the Indian aviation industry to create Safecity, an online platform that relies on anonymous crowd sourcing to document sexual harassment and abuse in public spaces.  “It’s the stories that connect more of us and give us courage to break the silence.  When you can see a database — we find it’s really powerful when you invite police and elected officials in the room and demand accountability.”
The proliferation of cell phones around the world has also empowered civil rights advocates to record and report instances of abuse and advocate for change.  Tanya Karanasios, deputy program director at WITNESS, an international nonprofit organization that trains and supports people using video in their fight for human rights, described how Afro-Brazilians were able to raise greater awareness of police abuse by recording incidents.  This brought attention from the international media and public defenders, who used the evidence to pursue prosecutions of some of the officers.
However, while data and images collected by citizens and civil organizations can shine a spotlight on human rights abuses, it can be difficult to harness disparate data to hold oppressors accountable.  There are many challenges with collecting, preserving, and analyzing images and data from many disparate sources, said Keith Hiatt, who leads the information systems management section at the United Nations International, Impartial, and Independent Mechanism for Syria (IIIM), an entity created to collect, preserve, and analyze evidence of the most serious violations — such as war crimes and crimes against humanity —from many different sources.  The IIIM prepares case files to help bridge the gap between data collection and accountability.
‘Example After Example of Real Harms’
Despite the good that digital technologies can bring to humanitarian and human rights work, they can be applied to interfere with this work as well. “The fact of the matter is that a lot of the activism, organization, and civil society movements we all care about…take place on platforms that were not designed for security,” said Ron Deibert, who directs the Citizen Lab at the University of Toronto. Meanwhile, he noted, governments and private surveillance companies hired by adversaries are employing digital tools and data collection to thwart human rights activists. 
And although big data and AI are sometimes heralded as fixes to societal issues such as inequality and bias, data collection and algorithm design can unintentionally perpetuate these problems. “We are seeing example after example of real harms due to AI…, automated technologies, and other forms of algorithm-driven technologies,” said Mark Latonero, research lead for data and human rights at the nonprofit research institute Data & Society.  For instance, research has shown that facial recognition technologies are demonstrably biased against minorities, which has led the city of San Francisco to ban their use. 
“One of the inherent problems is the societal presumption that that data is objective — that it doesn’t have history, it doesn’t have politics, and it reflects reality properly,” said Rashida Richardson, director of policy research at New York University’s AI Now Institute.  “None of those things are true, based on current data collection and use practices.”
‘Hard Work Ahead’
Much work needs to be done to capitalize on the benefits of digital technologies to advance human rights — while ensuring that these same technologies do not infringe on them. “We as a country need to be re-engaging in human rights mechanisms,” said keynote speaker Kaye. “The further we get from those basic mechanisms of human rights and how they’re working in practice, the harder it is for us to influence them and to educate ourselves about what is happening around the world.  It’s education. It’s engagement. It’s law.”
Technology companies have become governors of online space, and in turn, are shaping freedom of expression around the world.  For instance, approximately 85 percent of Facebook’s 2.5 billion active users are outside of the U.S., with many in countries where access to information is much more limited.  Kaye referenced a recent announcement by Facebook that it would use international human rights standards to make judgments about expression on the platform.  
“In an ironic way, the companies might be — if we push them — a leader in thinking about the way that human rights can have an impact on our lives, and the way we think about privacy and expression and other rights.”
“Everybody knows we are in the midst of a global battle for dominance in AI technology, but we are also in the midst of a geopolitical battle with respect to the norms and values that will guide regulation of AI,” noted Eileen Donahue, executive director of the Global Digital Policy Incubator at Stanford University’s Center for Democracy, Development, and the Rule of Law. “What I worry about most is that we could be having a global, unconscious drift toward digital authoritarianism."
Although the human rights framework isn’t perfect, it is a good model to build upon in order for governments, industry, and civil society to protect rights while reaping the benefits of digital technologies, said Donahue  “We have a lot of hard work ahead to articulate in a compelling way how [digital governance] applies with respect to freedom of expression, freedom of assembly, right to privacy, equal protection, and non-discrimination. It’s going to be a cross-disciplinary, multi-stakeholder process.”

http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=9302019&utm_source=NASEM+News+and+Publications&utm_campaign=0596c47960-NAP_mail_new_2019_10_07&utm_medium=email&utm_term=0_96101de015-0596c47960-107497293&goal=0_96101de015-0596c47960-107497293&mc_cid=0596c47960&mc_eid=37f271fc0d

Addressing the Opioid Crisis with Technology


From 2006 to 2012, 76 billion oxycodone and hydrocodone pills were distributed throughout the US. That’s an average of nearly 11 billion pain pills per year. Additionally, a report from the Centers for Disease Control and Prevention found that only one overdose-reversal drug was dispensed for every 69 high-dose opioid prescriptions.
Clinicians can play a significant role in addressing the opioid epidemic that takes the lives of tens of thousands of people every year.
Evaluate Existing Prescribing Practices
One study shows that around six percent of patients who undergo (minor or major) surgery will experience persistent opioid use after 90 days. This is especially problematic when some providers are writing prescriptions for more than 100 pain pills. Between 2011 and 2016 alone, thousands of surgeons across the US wrote prescriptions after surgeries for dozens of opioid pills—far above most post-surgical guidelines.
While there are certainly factors like complications or automated prescribing programs that default to preset amounts, surgeons can have a significant impact on the opioid crisis by reviewing their organization’s prescribing habits as well as their own.
How Technology Can Provide Life-Saving Information
Over 20 percent of US adults live with chronic pain. Additionally, pain has been cited as the top reason patients access the American healthcare system. That means all physicians and clinicians with prescribing power can positively affect the opioid crisis by taking more care when prescribing medications for pain management. However, many providers, particularly those in emergency medicine, don’t know when a patient has gotten opioids from previous emergency department (ED) visits or primary care physicians due to lack of insight into patient medical and prescription histories.
To address this problem, Alaska created statewide initiatives that included prescribing guidelines, public and physician education, and a prescription drug monitoring program (PDMP). This has helped many hospitals throughout the state gain insight into patient patterns and better track prescription opioid misuse. 
At Mat-Su Regional Medical Center in Alaska, one woman with major medical problems visited the ED with complaints of severe pain. Physicians didn’t realize she was already receiving opioids from her primary care provider, and the woman chose not to disclose it. This meant well-meaning physicians could have been justified in issuing another prescription, fueling a problem with substance use disorder, which could then result in overdose or even death.
Mat-Su had implemented Collective’s platform and integrated it with the state’s PDMP. Through this technology, physicians gained real-time information on a patient’s visit and prescription history, helping them make informed decisions. This visibility allowed Mat-Su physicians to see the above woman’s prescribing history and provide the care she really needed.
“With Collective, rather than making judgements about patients, we have actual data to reference,” says Anne Zink, MD, FACEP, and Emergency Medicine Director at Mat-Su. “This makes it a lot easier to have a conversation with the patient, starting with ‘Let’s see what you’re facing, what the underlying problem is, and why you’re really bouncing between providers.’”
Mat-Su has been able to keep patient satisfaction high while reducing the number of opioid prescriptions written by nearly 80 percent through local efforts, statewide initiatives, PDMP integration, and care collaboration fueled by technology.
Brittany Eastman Marketing Coordinator brittany.eastman@collectivemedical.com

Watch Your Wallet -- Avoid These 3 Money Scams


When it comes to taxes, Social Security, Medicare, and other facets of your financial life, scammers galore would love to rob you. Learn how to spot and avoid them.
Selena Maranjian (TMFSelena) Dec 29, 2019 at 8:03AM
There are few feelings worse than realizing you've been had -- especially if you've been taken to the cleaners in the process. It happens to many people, though, because there are gobs of financial scams out there, and plenty of scammers looking for people to take advantage of.
Here's a look at three common scams.
Tax scams
A common kind of tax scam these days occurs when a con artist files a tax return for you -- and claims your refund. He or she will have to have gotten some critical information from you first, such as your full name, address, and Social Security number. All kinds of financial mayhem can ensue if you don't guard such information and are not judicious in giving it out.
How does a scammer get that information from you? Well, they may just call you and pretend to be with an organization you trust, such as the IRS, the Social Security Administration (SSA), your bank, or your credit card company. They may explain that there's some problem and to fix it, they will need to verify your information. This is called "phishing," as in fishing for information. Similarly, they may email you, pretending to be a trusted organization, and get you to click a link in order to solve a worrisome problem -- perhaps, for example, they will pretend to be a bank and will suggest that a $900 withdrawal (that you didn't make) will go through unless you click a link and tell them not to process it. You might then be asked for personal information. Or perhaps the link will cause some malware to run on your computer.
Making matters worse, many scammers employ "spoofing" tricks. They can call you and have their phone number display as coming from the IRS or the Social Security Administration or a business or agency you trust. They can also make their fake emails look a lot like those from known organizations, complete with the companies' logos and official-sounding language. Try to be skeptical whenever any entity reaches out to you and wants your personal information -- especially if they're trying to alarm you.
Back to that tax scam: How might you prevent it, beyond safeguarding your personal information? The best way is not to procrastinate about preparing and filing your return. If you get your taxes done and sent in early, you'll give the scammers much less time in which to try to steal from you. Also, know that the IRS doesn't call taxpayers asking for immediate payments to solve problems, and it doesn't email you about your refund or ask for your personal information via email, either.
A last tax scam to look out for is that of the "ghost" tax preparer. That's when you pay someone to prepare your return, but he or she doesn't sign it and instead has you sign it. That makes it seem as if you prepared it, and you will be on the hook if the unscrupulous preparer changed some of your numbers, perhaps to qualify you for some tax breaks. Some ghost preparers will also quietly divert refunds to their own accounts. If you're paying someone to prepare your return, don't just go with a stranger at a booth somewhere. Ask around for recommendations or go to a reputable company.
Social Security scams
Similarly, scammers use many of the techniques above to try to get at your Social Security benefits. They may call or email you to alarm you, saying that your Social Security number has been canceled or suspended, for example. Once they have the information they need, they can set up an account in your name with the SSA and use their address and bank account in order to collect your benefits.
One way to prevent this is to set up a my Social Security account with the SSA before a scammer does. You don't have to be in or near retirement to do so -- you can do it at any age. Upon doing so, you'll be able to see the SSA's record of your earnings for all of your working years, along with estimates of the benefits you'll collect if you start collecting at different ages.
Remember that like the IRS, the SSA doesn't call you to get personal information. If you're not sure whether a certain call is legitimate, try hanging up, looking up its number online, and calling the agency yourself. (You'll find the Social Security Administration at 800-772-1213 and the IRS at 800-829-1040.) Then you can ask about the status of your account or if there are any problems. (There probably aren't.)
Medicare scams
Now that you know what to look out for, you can probably defend yourself well against Medicare scams. In many of those, scammers will call or email you with alarming news -- such as that your Medicare will be canceled unless you quickly provide some personal information to the caller, such as your Medicare number. Understand that Medicare doesn't call people -- and it doesn't need to be told your Medicare number, as it already knows it.
Don't let any callers or emails tempt you into changing your healthcare coverage, either, as they can be touting either a phony nonexistent plan or a plan that offers much less coverage than it may seem to. It is good to shop around for the best Medicare plan for yourself, but do your own digging and shopping -- don't respond to strangers contacting you.
The more you learn about scams and scamming techniques, the less likely you'll be to fall for them. As you go through your financial life, saving, investing, paying taxes, collecting benefits, getting healthcare, and so on, be alert for those who want to take advantage of your hard work.

Amazon Is Not a Threat to This Industry

Amazon.com has been one of the most innovative and disruptive companies of this century, with incredible success in areas that lie outside of what has been historically perceived as its core business (book selling).

Thus every announcement or speculation that Amazon will enter into a particular industry sends stocks of that industry into a tailspin. Investors sell first and ask questions later. When Amazon announced its purchase of Whole Foods, grocery stores declined as much as 30%. Even Tesco separated by an ocean from Whole Foods, was down on that news.

A big part of Amazon’s success has come from not being taken seriously by its competition. Amazon was able to create a huge lead in AWS (Amazon Web Services) because the competition (Alphabet and Microsoft did not give Amazon enough respect. Competitors thought, "what does a book seller know about the cloud?" Well, according to Amazon CEO Jeff Bezos, such thinking gave Amazon a much bigger lead over its rivals. Today, everyone takes Amazon seriously. Indeed, fear of Amazon is reaching paranoia levels.

McKesson shares, for example, took a 20% dive during the fourth quarter of 2017 on speculation that Amazon would start distributing pharmaceuticals in the U.S. As McKesson shareholders, my firm took this speculation seriously, but upon further investigation, it became evident that such concerns were overblown. After the market cooled off from fourth-quarter worry about Amazon, McKesson shares recovered.

Then in late January, news that Amazon, JPMorgan Chase, and Berkshire Hathaway will join forces to drive down U.S. health-care costs hit health-care sector stocks, including McKesson.

How big of a punch could this be? McKesson is the largest distributor of pharmaceuticals in the U.S. Its 2018 sales are on track to exceed $210 billion. It is important to point out that McKesson is not a retailer but a distributor. It is one of three railroads for drugs in the U.S. McKesson distributes drugs to thousands of independent pharmacies, as well as giants like CVS Health, Rite Aid and Walmart McKesson operates two distinct distribution businesses: branded and generics. Though these businesses may look similar on the surface, the economic models of branded and generic businesses are quite different.

In the distribution of branded drugs (about 70% of McKesson’s revenue and 30% of profits) McKesson has a fee-for-service model. Pharmaceutical companies want to be involved in high-value activities: chiefly, inventing and manufacturing drugs. Getting drugs to thousands of pharmacies on a timely basis and collecting accounts receivable is not the business they want to be in. They don’t have the scale and distribution know-how of McKesson, Cardinal Health, and AmerisourceBergen — that collectively control 90% of drug distribution in the U.S. Thus the likes Pfizer and Bristol-Meyers Squibb pay drug distributors a small "fee for service," and pharmaceutical companies (not distributors) negotiate prices with pharmacies.

More than 90% of McKesson’s profit in this segment is driven by volume, while just 10% is linked to changes in drug prices. Pfizer, for instance, despite its might, would still have higher distribution costs than McKesson because it doesn’t have McKesson’s scale and focus on distribution efficiency. So Pfizer is happy to pay McKesson this service fee and not think about drug distribution.

In its generic drug distribution business (about 30% of sales, 70% of earnings), McKesson uses its enormous buying power to buy drugs at low prices from generics manufacturers and sell at higher prices to pharmacies. Since it can source the same drug from various manufacturers, it leverages better prices from the likes of Mylan and Teva Pharmaceuticals Industries. Drug distributors are a significant deflationary force in generic pricing — good for consumers, not great for Teva or Mylan.

So McKesson has a wide protective moat, which includes the distinct possibility that Amazon’s adventure into drug distribution could lead to miserable failure. Here’s why:

1. Amazon cannot match McKesson’s buying power or negotiating power when it comes to generics. Current Amazon sales of pharmaceuticals are somewhere between zero and slightly above zero. McKesson’s sales are pushing $210 billion, about $65 billion of which comes from generics.

Walmart is the fourth-largest pharmacy in the U.S., with sales of $20 billion. It had distributed drugs, but in 2016 it signed a distribution deal with McKesson. Walmart realized it could get better prices for generics through McKesson. Amazon, with near-zero sales, doesn’t stand a chance.

2. Amazon has no structural advantage. In the fight against Barnes & Noble and Best Buy, Amazon could charge lower prices than brick-and-mortar retailers because it had a structural advantage — it did not own stores and have all the extra costs associated with them. On one of his conference calls, McKesson CEO John Hammergren said his company was Amazon before Amazon was Amazon. Indeed. McKesson has highly specialized warehouses designed to distribute drugs. It can get any drug to any pharmacy in the U.S. within hours.

3. McKesson’s pretax margins are just 1.7%. If Amazon is looking to cut fat in the pharmaceutical industry, this is not where the fat is.

4. Distributing and selling drugs is not like selling or distributing most anything else. First, some drugs require refrigeration and others are controlled substances. Distributing them puts an extra regulatory (and self-policing) burden on distributors. McKesson has paid fines and recently received plenty of negative publicity from "60 Minutes" for distributing opioid pain medications to legal pharmacies who illegally sold the medicine on the black market.

Second, unlike in almost any other industry, pharma consumers are price-insensitive. If you are on Medicare, Medicaid, or a copay/low-deductible private insurance plan, you really don’t care if you are paying the lowest price because you don’t see the price (other than for copay). For this group of drug consumers, which constitutes the bulk of the U.S. population, lower drug prices are not an incentive to switch.

Moreover, let’s say Amazon starts an online pharmacy and self-distributes. Internet-savvy millennials are not the ones consuming most of the drugs in the U.S. Their parents and grandparents are. This demographic still has brick-and-mortar habits that are less likely to be broken anytime soon. Also, major pharmacies already have mail-order operations. It would be logical for Amazon to try to get into the almost-trillion-dollar pharma business, but its success here will be limited, and it will take decades to gain a meaningful market share

5. Suppose Amazon opens an online pharmacy and succeeds. It would probably take five to 10 years to reach sales of, let’s say, $10 billion (half of Walmart’s current drug sales). Let’s assume that Amazon self-distributes and will not use McKesson, or that it decides to employ the services of Cardinal Health. This would steal less than a year of current growth from McKesson, in five to 10 years.

Put simply, the laws of economics still apply — even to Amazon. Drug distributors are strong financially and have great scale and a tremendous purchasing-power advantage. Distributors’ stocks may take a dive but their business will be fine in the long run. The only competitive advantage Amazon has against drug distributors is that Wall Street completely ignores its profitability and focuses only on revenue growth.

McKesson is one of the U.S. stock market’s most interesting investments. Its business is future-proof. The demand for its product is not cyclical and is likely to continue to grow as the U.S. population ages. Higher or lower interest rates, recession or no recession, inflation or deflation, McKesson’s earnings power will continue to march ahead for a long time.

McKesson has a conservative balance sheet; it can pay off its debt in less than two years. McKesson pays a lower dividend than its competitors, but it has purchased a third of its shares over the last decade. Expected earnings of about $13 a share this year could grow to $15 in 2019. At a conservative 15 times earnings, McKesson is worth about $225 a share. However, McKesson has spun off its technology business into Change Healthcare, which could go public in 2019. McKesson owns 70% of Change Healthcare, and my firm estimates McKesson’s interest is worth about $25-$30 a share. Thus, a conservative estimate of McKesson’s value is about $250.

Accordingly, my firm took advantage of recent weakness in McKesson’s shares and increased our position.


Vitaliy Katsenelson, CFA Student of Life, CEO

I am the CEO at IMA, which is anything but your average investment firm. (Why? Get our company brochure here, or simply visit our website).

In a brief moment of senility, Forbes magazine called me "the new Benjamin Graham."  

I’ve written two books on investing, which were published by John Wiley & Sons and have been translated into eight languages. (I’m working on a third - you can read a chapter from it, titled "The 6 Commandments of Value Investing" here).

And if you prefer listening, audio versions of my articles are published weekly at investor.fm.

Baylor Dallas heart transplant a ‘Christmas miracle’


A brutal case of pneumonia four years ago put Richard Powell on a path that would eventually lead him to a Baylor University Medical Center at Dallas operating room for a heart transplant weeks before Christmas.
When Powell first got sick in early 2010, he was treated at a hospital in his home city of Monroe, Louisiana, for about a month. He was in an induced coma for days. The 61-year-old insurance salesman suffered septic shock and nearly died.
“They called my family together and told them they might want to come in and say their goodbyes,” said Powell, who is also a diabetic. “I was fortunate … God’s leniency was enough to let me survive.”
But Powell’s health problems were only beginning. Over the next few years, because of poor health, the divorced father and grandfather spent time living with his brother in Houston and his adult son in Trophy Club, with periodic stays at his own home in Monroe.
“He could not get well,” said his son, Ryan Powell. “He was coming back and forth to Dallas and just couldn’t really get healed up.”
Richard Powell had some of his toes amputated because of complications from his diabetes, among other problems.
On Memorial Day weekend of last year, Ryan, his wife and two sons visited Richard in Monroe.
“He looked awful,” Ryan said of his father. “He was short of breath. He was [suffering from] an infected foot … we just knew something major was wrong and he wasn’t getting the care he needed.”
After consulting with a physician friend, Ryan decided to bring his father to Texas for care. Over the ensuing months, he was treated at Baylor Regional Medical Center at Grapevine and Baylor Dallas for congestive heart failure. Doctors told him his heart was pumping at about 15 percent of capacity and he needed a Left Ventricular Assist Device (LVAD). Ultimately, he would likely need a transplant.
Gonzalo V. Gonzalez-Stawinski, MD, chief of heart transplantation at Baylor University Medical Center at Dallas, completed the LVAD surgery in August of 2013 and, over the next few months, Richard showed great progress. He moved back to Monroe and went back to work. He would come to Dallas for checkups and the doctors here advised him in recent months that he would be a good candidate for a heart transplant.
Electrical issues with his LVAD in the weeks since Thanksgiving landed him back in Dallas and he was activated on the transplant list earlier this month. Within days, on December 11, Richard Powell got the call. A match donor heart was headed to Dallas for him.
The transplant — believed to be the record 94th conducted by Baylor Dallas this year — was a success and Richard was out of the hospital and back at his son’s home eight days later.
“It’s a Christmas miracle, it truly is,” Ryan said.
Richard said he feels lucky that his son’s family happened to live in the Dallas area. Otherwise, he likely would not have ended up at Baylor for his treatment.
“I just feel like it was divine intervention that I’m here,” he said. “It is just really a miracle. Things have just fallen in place through God’s order and God’s time.”
Richard has a long recovery ahead, as the first year after a heart transplant is typically the toughest. His diabetes is another potential complication, so the cardiac transplant team will be monitoring him closely.
His care team has little doubt that he is up for the next challenge.
“He’s been an amazing patient,” said Sandra Carey, PhD, ANP-BC, the outpatient nurse practitioner for transplant and advanced heart failure at Baylor Dallas. “He’ll do whatever you ask of him.”
The post-transplant recovery is “a very individual journey,” Carey said. But “I think because he’s so motivated he’ll do extraordinarily well.”

UnitedHealthcare Makes the Top 100 Most Valuable U.S. Brands

Dec 16, 2019

Over the last 40 years, UnitedHealthcare has focused on connecting people to better health by building a variety of health plans and innovative programs. This year, for the first time, that effort is recognized in Kantar BrandZ’s Top 100 Most Valuable U.S. Brands.
BrandZ estimates the value and equity of more than 100,000 brands across 45 countries. Since 2006, they have released annual global rankings and only recently began producing country-specific rankings. Brands are chosen based on their financial results and whether they are meaningful, unique and easily recognizable in the eyes of consumers.
Only four newcomers made the U.S. list for 2020 – UnitedHealthcare is one of them with a ranking of 53 out of 100 and a brand valuation of $14 billion. 
The company’s focus on bringing relevant health plans to market is among the primary reason for the recognition, but UnitedHealthcare has also made significant steps to help elevate its brand and to position itself as a more consumer-centric company in recent years.
For example, the company established a purpose focused on connecting the world to better health one person at a time. It also began using creative messaging, like their recent Destination Wedding and Take Advantage commercials, to communicate their offerings in a humorous way.
As a result, the UnitedHealthcare brand is becoming more distinguished among consumers and more meaningful to the employees who work each day to help people live healthier lives and to help make the health system work better for everyone.
Watch the video below to hear firsthand how a newfound purpose and a focus on the individual have helped evolve UnitedHealthcare into now being recognized as one of the nation’s most valuable brands.
https://newsroom.uhc.com/experience/brand-value.html?Source=LinkedIn&Medium=Dark&AdID=COR170B

The Caregiver’s Journey: Caring for Others, Caring for Yourself


Esta entrada también está disponible en: Español
For those of you experiencing both the joys and challenges of caring for elderly loved ones, this shout-out is for you. I honor you and encourage you in your compassionate mission. I also want to nudge you to make sure to take time to care for yourself. I’ve included some thoughts and resources below meant especially for you.   
I don’t have to tell you we’re all aging. It’s a natural part of life, a human experience we all have in common. And, our population is also aging. That’s why caregivers are playing an even larger role in the lives of our communities. 
Many caregivers won’t appear on employment reports, and because of that they often go unnoticed. But we notice don’t we, dear readers? Because many of us count ourselves and our friends among them.
In many cases, we’re both doing our best to both raise our kids and care for aging parents, abuelos and abuelas, tíos and tías. And if we’re not yet, we likely will be soon.
But if there were any doubt about the huge number of caregivers out there, consider that in 2015, according to the National Alliance for Caregiving and AARP, about 34.2 million Americans provided unpaid care to an adult age 50 or older in the 12 months prior. That’s a whole lot of caregiving.
In addition to all of that, consider, too, that often the caregiver and the person they care for are seniors, so both may be experiencing the many physical challenges associated with aging.
Awareness is the First Step to Understanding
I recently had an eye-opening experience. A sneak peek into an interactive senior sensitivity workshop called Trading Ages Virtual Reality that uses virtual reality technology to provide participants with a first-hand experience of the challenges associated with aging, including hearing loss, vision changes and loss of dexterity. I wrote about it here
If a picture is worth a thousand words, then how many more for a virtual reality experience? I’ll answer that myself: Infinite. I won’t repeat everything from that earlier post, except to say the experience’s benefits went far beyond the advantages of seeing life from another’s shoes. If ever so briefly, it gave me a chance to feel some of the emotions, not only from an older person’s perspective, but from a caregiver’s perspective, too.
Another benefit of the Trading Ages workshop, one I hadn’t considered beforehand, was the chance to get a leg up on my own personal journey with aging. Seeing the world from the shoes of another gave me insight into my own future. It gave me a chance to know, a chance to prepare.
With that, here are three simple tips for caregivers to remember.
Three Simple Tips for Caregivers
1. Small Adjustments, Big Differences
Small adjustments both around the house and when out and about can make a big difference for those in your care. Each person’s needs are different, but here are some ideas to get your own creative ideas flowing: 
·         Moving a throw rug out of a main pathway to avoid fall risks 
·         Changing a lamp to a brighter bulb
·         Printing labels for drawers 
·         Using larger font sizes on labels 
·         Carrying a magnifying glass and a flashlight 
·         Speaking in a slightly lower pitch 
·         Providing an extra-long shoe horn 
·         Sitting at a restaurant table where background noise is minimized 
·         Keeping extra straws handy 
·         Carrying facial tissues
·         Providing cordless headphones 
·         Keeping up on new adaptive living products  
2. Compassionate Communication
In Thoreau’s immortal words from Walden, “To be in company, even with the best, is soon wearisome and dissipating.” Sometimes even the most affable person can get grumpy, including caregivers and those in their care. 
We’re all human. As a caregiver, sometimes we must consciously reframe our responses to statements that originally sound like criticism.
For example, let’s say the person you are caring for says, “Why don’t you ever bring home my favorite bread from the corner bakery?” I might want to say, “I’ve told you a hundred times that bakery closed five years ago!” Instead, I might reframe the apparent criticism as an expression of loss and say something like this, “Oh, I know, I miss that bread, too. It is so delicious. I wish that bakery was still open.”
3. Self-Care
We have to take care of ourselves if we are going to take care of others. However, it’s easy to let this priority slip to the bottom of the to-do list. From my experience, I know how important it is for caregivers to be compassionate with ourselves. We need to treat self-care just as important as any other top priority. 
Ask friends and family to commit to help out with certain household responsibilities or to step in for a few hours per week. With the support of the community, you might make time for some respite, keep engaged in social activities and enjoy nutritious meals with loved ones.  Finally, be sure to get your sleep. And, breathe.
For more tips on self-care, check out more ideas here
Thank you for all you do.
About Trading Ages® 
SCAN developed Trading Ages® for its own employees, but quickly saw how other organizations—and the seniors they serve—could benefit. Trading Ages® encourages participants to develop insight and empathy through active encounters with the physical, social and emotional aspects of aging.
Trading Ages® is only available in Southern California. To request a Trading Ages® workshop for your organization, contact TradingAges@SCANHealthPlan.com.
Thanks to the great folks at SCAN Health Plan for making this post possible. Since its founding in 1977, SCAN has been a mission-driven organization dedicated to keeping seniors healthy and independent. That’s a great thing.
Don’t forget to join the conversation at #SCANstages, #SCAN100over100 and #GatherAndShareWithSCAN hashtags on social media.